Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Rittmaster

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Fertility and Sterility|May 20, 1998
Role of the ovary in the adrenal androgen excess of hyperandrogenic womenR Azziz, R S Rittmaster, L M Fox, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1984
Potency and specificity of a growth hormone-releasing factor in a primate and in vitroO F Almeida, H M Schulte, R S Rittmaster, et al.
The Prostate|November 13, 2004
Differential alterations in 5alpha-reductase type 1 and type 2 levels during development and progression of prostate cancerLynn N Thomas, C B Lazier, R Gupta, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1987
The relationship of saline-induced changes in vasopressin secretion to basal and corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol secretion in manR S Rittmaster, G B Cutler, P W Gold, et al.
Endocrinology|February 1, 1995
Evidence for atrophy and apoptosis in the ventral prostate of rats given the 5 alpha-reductase inhibitor finasterideR S Rittmaster, A P Manning, A S Wright, et al.
Prostate Cancer and Prostatic Diseases|April 10, 2013
Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE studyS J Freedland, R J Hamilton, L Gerber, et al.
The Journal of Clinical Endocrinology and Metabolism|June 14, 2000
Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronateR S Rittmaster, M Bolognese, M P Ettinger, et al.
The Journal of Urology|August 18, 2004
Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancerG L Andriole, P Humphrey, P Ray, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1985
Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjectsR S Rittmaster, G B Cutler, D O Sobel, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1985
Growth hormone responses to continuous infusions of growth hormone-releasing hormoneM C Gelato, R S Rittmaster, O H Pescovitz, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Fertility and Sterility|May 20, 1998
Role of the ovary in the adrenal androgen excess of hyperandrogenic womenR Azziz, R S Rittmaster, L M Fox, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1984
Potency and specificity of a growth hormone-releasing factor in a primate and in vitroO F Almeida, H M Schulte, R S Rittmaster, et al.
The Prostate|November 13, 2004
Differential alterations in 5alpha-reductase type 1 and type 2 levels during development and progression of prostate cancerLynn N Thomas, C B Lazier, R Gupta, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1987
The relationship of saline-induced changes in vasopressin secretion to basal and corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol secretion in manR S Rittmaster, G B Cutler, P W Gold, et al.
Endocrinology|February 1, 1995
Evidence for atrophy and apoptosis in the ventral prostate of rats given the 5 alpha-reductase inhibitor finasterideR S Rittmaster, A P Manning, A S Wright, et al.
Prostate Cancer and Prostatic Diseases|April 10, 2013
Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE studyS J Freedland, R J Hamilton, L Gerber, et al.
The Journal of Clinical Endocrinology and Metabolism|June 14, 2000
Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronateR S Rittmaster, M Bolognese, M P Ettinger, et al.
The Journal of Urology|August 18, 2004
Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancerG L Andriole, P Humphrey, P Ray, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1985
Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjectsR S Rittmaster, G B Cutler, D O Sobel, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1985
Growth hormone responses to continuous infusions of growth hormone-releasing hormoneM C Gelato, R S Rittmaster, O H Pescovitz, et al.
Pageof 7